ASPN stock

Is Aspen Aerogels Inc (ASPN) overvalued? · rev $452.7M

Aspen Aerogels Inc (ASPN) is a building products & equipment company listed on US.

This page asks whether Aspen Aerogels Inc (ASPN) looks expensive on cached numbers — not a short thesis.

Latest reported ASPN revenue for 2024-12-31 was $452.7M. Net income was $13.4M. Revenue was up 89.6% from 2023-12-31 to 2024-12-31. ASPN currently screens at market cap $515.5M.

ASPN currently screens at market cap $515.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next ASPN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the ASPN stock page for the full model, not this heading.

Not investment advice.

Full ASPN analysis